RGEN vs XRAY
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
RGEN
XRAY
Investment Advisor Scores
XRAY
AI Analyst Insights
Detailed Metrics Comparison
| Metric | RGEN | XRAY | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 64.5161 | 6.4809 | XRAY |
| PEG Ratio | 1.7304 | 0.648 | XRAY |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 10.9% | -7.5% | RGEN |
| Earnings Growth | -65.9% | 15.2% | XRAY |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.4/100 | 43.0/100 | RGEN |
| Profit Margin | -1.5% | -3.4% | RGEN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
RGEN
NeutralMixed signals - no dominant trend phase, RSI 47
XRAY
NeutralMixed signals - no dominant trend phase, RSI 53
Fundamentals Snapshot
| Metric | RGEN | XRAY |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 65.1 | 7.8 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | -0.1% |
| Gross Margin | 0.5% | 0.5% |
| Operating Margin | 0.1% | 0.0% |
| EPS | -0.21 | -0.61 |
| Dividend Yield | — | 0.02% |